Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSOX in locally advanced or advanced gastric cancer
NCT03263741Phase 2Unknown
- Sponsor
- Affiliated Hospital of Qinghai University
- Start
- Apr 2017
- Primary completion
- Sep 2019
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, tegafur, oxaliplatin in gastric cancer (GC), gastroesophageal adenocarcinoma, sponsored by Affiliated Hospital of Qinghai University. Status: unknown.
02
Drugs
Paclitaxel Micelles for Injectiontegafuroxaliplatin
03
Conditions
gastric cancer (GC)gastroesophageal adenocarcinoma
Beyond the preview
Go deeper on NCT03263741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03263741.